Kathleen S. Wright Associates »

Supernus Pharmaceuticals shares owned by Kathleen S. Wright Associates

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Kathleen S. Wright Associates from 13F filings

Historical chart of Kathleen S. Wright Associates investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Kathleen S. Wright Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Kathleen S. Wright Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $23k 475 47.79
2025-06-30 $15k 475 31.52
2025-03-31 $16k 475 32.75
2024-12-31 $17k 475 36.16
2024-09-30 $15k 475 31.18

More positions owned by Kathleen S. Wright Associates

Vanguard Index Fds &p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del L B New (BRK.B)
Vaneck Etf Trust Rngstr Wde Moat (MOAT)
Ishares Tr -3 Mnth Treasry (SGOV)
Vanguard Index Fds Rowth Etf (VUG)
Vanguard Index Fds Id Cap Etf (VO)
Wisdomtree Tr S Smallcap Fund (EES)
Vanguard Index Fds Otal Stk Mkt (VTI)
Vanguard Whitehall Fds Ntl Dvd Etf (VIGI)
American Express Om (AXP)
Schwab Strategic Tr Ntl Eqty Etf (SCHF)
Ishares Tr Sci Usa Min Vol (USMV)
Schwab Strategic Tr Ntl Sceqt Etf (SCHC)
Brookfield Corp L A Ltd Vt Sh (BN)
Ea Series Trust S Quan Value (QVAL)

View all positions for Kathleen S. Wright Associates

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Dimensional Fund Advisors
Armistice Capital
Macquarie Group
State Street Corporation
Point72 Asset Management
Renaissance Technologies
Citadel Advisors
Geode Capital Management
Stephens Investment Management Group
Loomis, Sayles and
Woodline Partners
Goldman Sachs Group
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals